Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries

首圖

SINGAPORE -- (BUSINESS WIRE) -- Prestige Biopharma Limited (KRX: 950210, hereafter referred to as 「Prestige」) and Intas Pharmaceuticals Limited (hereafter referred to as 「Intas」) today annou......